TransCode Therapeutics - RNAZ Revenue Change YoY (Last 12 Months)

Graphic logo of transcodetherapeutics.com (RNAZ)

This chart of core revenue YoY dynamics over a rolling 12-month period confirms that TransCode Therapeutics (RNAZ) remains independent of market volatility due to medtech demand. The value 0.00 represents the current level of the metric. TransCode Therapeutics (RNAZ) is implementing RNA therapy against brain and breast tumors using a unique molecule delivery method. Developments in RNA cellular transport are creating valuable patent capital.

RNAZ - TransCode Therapeutics, Inc. Sales Growth YoY (TTM) over the range 02/11/2024 - 11/15/2026

TransCode Therapeutics Inc. (RNAZ) - metric breakdowns and financial figures

- stock quotes and analyst forecast:
Price Performance Chart transcodetherapeutics.com|RNAZ - Consensus Target
- issuer market value details:
Market Value TransCode Therapeutics, Inc.|RNAZ - Enterprise Value
- issuer book value statistics:
Accounting Value of a Share TransCode Therapeutics|RNAZ - Book Capitalization|Market-to-Book Ratio transcodetherapeutics.com|RNAZ - Aggregate Company Assets
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio TransCode Therapeutics|RNAZ - Long-Term Debt to Capital|Short-Term Debt to Capital TransCode Therapeutics|RNAZ - Company Debts|Debts to Book Capitalization Ratio TransCode Therapeutics, Inc.|RNAZ - Company Long-Term Debts|Short-Term Debt TransCode Therapeutics|Quick Ratio transcodetherapeutics.com
- earnings and market ratios statistics:
RNAZ - Net Income|Future Net Profit TransCode Therapeutics|RNAZ - P/E Multiple|Market Cap to Projected Earnings TransCode|RNAZ - PEG Multiple|Enterprise Value to EBITDA Ratio TransCode Therapeutics Inc.|RNAZ - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters TransCode Therapeutics|RNAZ - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months transcodetherapeutics.com|RNAZ - Earnings per share growth in current year|Projected earnings per share growth rate for next year TransCode Therapeutics
- sales revenue and business income indicators:
RNAZ - Revenue and Sales Volume|Projected Sales Volume transcodetherapeutics.com|RNAZ - Market Cap to Revenue|Future Price to Revenue TransCode Therapeutics, Inc.|RNAZ - Sales Growth YoY (TTM)
Analysis of all company metrics:transcodetherapeutics.com, RNAZ
Brand item of TransCode Therapeutics, Inc.

This indicator measures the volatility of revenue growth rates over a rolling twelve-month period, allowing for an assessment of the stability of incoming cash flows. Analyzing the relative year-over-year (LTM) revenue dynamics helps investors identify the risks of sharp income fluctuations, which is critical for TransCode Therapeutics (RNAZ), as the company utilizes outsourcing for drug synthesis via CMOs to minimize capital expenditures on its own laboratories.

Who TransCode Therapeutics competes with

Annual Revenue Growth (Last Twelve Months) Tempus AI, Inc (TEM)|QGEN: Revenue Growth YoY (Last 12 Months)|Ionis Pharmaceuticals (IONS) - Revenue Growth YoY (Last 12 Months)|Repligen (RGEN) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) Avidity Biosciences, Inc.|Sales Growth YoY (Last Twelve Months) CRISPR Therapeutics|WGS - Revenue Growth Rate YoY (Last Twelve Months)|Sales Growth YoY (TTM) RARE|Revenue Change YoY (Last 12 Months) BEAM|Sales Growth YoY (TTM) SRPT (Sarepta Corp)|TWST - Revenue Growth YoY (Last 12 Months)|TXG: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Intellia Therapeutics|STOK: Sales Growth YoY (TTM)|BLFS - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) WVE|MAZE: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Sionna Corp (SION)|Annual Revenue Growth (Last Twelve Months) Prime Medicine Bio|Sales Growth YoY (TTM) TSHA (Taysha Gene Therapies Inc)|Sales Growth YoY (TTM) uniqure.com QURE|MeiraGTx Holdings - Sales Growth YoY (TTM)|RGNX - Sales Growth YoY (TTM)|SLDB (Solid Corp) - Revenue Growth YoY (Last 12 Months)|Revenue Growth Rate YoY (Last Twelve Months) Ocugen Corp OCGN|PACB (Pacific Biosciences) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) BNTC|Sales Growth YoY (TTM) DSGN|Revenue Growth YoY (Last 12 Months) Rocket Pharma RCKT|Annual Revenue Growth (Last Twelve Months) FDMT|Sales Growth YoY (TTM) Lexeo Therapeutics LXEO|KRRO - Sales Growth YoY (Last Twelve Months)|EDIT (Editas Medicine, Inc.) - Sales Growth YoY (Last 12 Months)|SLN: Sales Growth YoY (TTM)|ProQR - Revenue Dynamics YoY (Last Twelve Months)|CDXS (Codexis) - Sales Growth YoY (TTM)|Sangamo (SGMO) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) NAUT|Revenue Growth YoY (Last 12 Months) Metagenomi, Inc. MGX|Sales Growth YoY (Last Twelve Months) Precision BioSciences DTIL|Revenue Dynamics YoY (Last Twelve Months) GBIO|BOLD - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Exicure Inc. XCUR|Imunon, Inc. (IMNN) - Sales Growth YoY (Last Twelve Months)|RXi Pharmaceuticals - Revenue Dynamics YoY (Last Twelve Months)|MBIO (Mustang Bio) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) bionanogenomics.com|Sales Growth YoY (TTM) APDN|Sales Growth YoY (Last Twelve Months) BLUE (Bluebird Bio)|Sales Growth YoY (Last Twelve Months) ImmunoPrecise Antibodies Ltd. IPA|Revenue Dynamics YoY (Last Twelve Months) OMGA|singulargenomics.com - Sales Growth YoY (TTM)|Regulus Therapeutics Inc. - Revenue Change YoY (Last 12 Months)|SYRS: Sales Growth YoY (TTM)|Sales Growth YoY (Last 12 Months) TBIO|TCON (TRACON Pharmaceuticals) - Sales Growth YoY (TTM)|Sales Growth YoY (Last 12 Months) UBX (unitybiotechnology.com)